Genome-wide association study of African and European Americans implicates multiple shared and ethnic specific loci in sarcoidosis susceptibility

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Adrianto, Indra ^a   Lin, Chee Paul ^a   Hale, Jessica J ^a   Levin, Albert M ^b   Datta, Indrani ^b   Parker, Ryan ^a   Adler, Adam ^a   Kelly, Jennifer A ^a   Kaufman, Kenneth M ^c,d   Lessard, Christopher J ^a,e   Moser, Kathy L ^a,e   Kimberly, Robert P ^f   Harley, John B ^c,d   Iannuzzi, Michael C ^g   Rybicki, Benjamin A ^b   Montgomery, Courtney G ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^f University of Alabama at Birmingham   (United States)

^g State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN; HLA DRB1 ANTIGEN; HLA DRB5 ANTIGEN; NOTCH4 RECEPTOR;

AFRICAN AMERICAN; ANXA11 GENE; ARTICLE; BTNL2 GENE; CONTROLLED STUDY; ETHNICITY; EUROPEAN AMERICAN; FEMALE; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HLA B GENE; HLA C GENE; HLA DRA GENE; HLA DRB1 GENE; HLA DRB5 GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOTCH4 GENE; SARCOIDOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; CAUCASIAN; ETHNOLOGY; GENETIC DATABASE; GENETIC PREDISPOSITION; GENETICS; MAJOR HISTOCOMPATIBILITY COMPLEX; META ANALYSIS (TOPIC); PEDIGREE; REPRODUCIBILITY;

AFRICAN AMERICANS; DATABASES, GENETIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; META-ANALYSIS AS TOPIC; PEDIGREE; REPRODUCIBILITY OF RESULTS; SARCOIDOSIS;

EID: 84865443261     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043907     Document Type: Article

References (100)

1. Iannuzzi MC, Rybicki BA, Teirstein AS, (2007) Sarcoidosis. N Engl J Med 357: 2153-2165.
2. Iwai K, Tachibana T, Takemura T, Matsui Y, Kitaichi M, et al. (1993) Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan. Acta Pathol Jpn 43: 372-376.
3. James DG, (1997) Descriptive definition and historic aspects of sarcoidosis. Clin Chest Med 18: 663-679.
4. Newman LS, Rose CS, Bresnitz EA, Rossman MD, Barnard J, et al. (2004) A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 170: 1324-1330.
5. Kucera GP, Rybicki BA, Kirkey KL, Coon SW, Major ML, et al. (2003) Occupational risk factors for sarcoidosis in African-American siblings. Chest 123: 1527-1535.
6. Rybicki BA, Amend KL, Maliarik MJ, Iannuzzi MC, (2004) Photocopier exposure and risk of sarcoidosis in African-American sibs. Sarcoidosis Vasc Diffuse Lung Dis 21: 49-55.
7. Rybicki BA, Iannuzzi MC, Frederick MM, Thompson BW, Rossman MD, et al. (2001) Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 164: 2085-2091.
8. Schurmann M, Reichel P, Muller-Myhsok B, Schlaak M, Muller-Quernheim J, et al. (2001) Results from a genome-wide search for predisposing genes in sarcoidosis. AmJRespirCrit Care Med 164: 840-846.
9. Valentonyte R, Hampe J, Huse K, Rosenstiel P, Albrecht M, et al. (2005) Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 37: 357-364.
10. Iannuzzi MC, Iyengar SK, Gray-McGuire C, Elston RC, Baughman RP, et al. (2005) Genome-wide search for sarcoidosis susceptibility genes in African Americans. Genes Immun 6: 509-518.
11. Hofmann S, Franke A, Fischer A, Jacobs G, Nothnagel M, et al. (2008) Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis. Nat Genet 40: 1103-1106.
12. Franke A, Fischer A, Nothnagel M, Becker C, Grabe N, et al. (2008) Genome-wide association analysis in sarcoidosis and Crohn's disease unravels a common susceptibility locus on 10p12.2. Gastroenterology 135: 1207-1215.
13. Siltzbach LE, James DG, Neville E, Turiaf J, Battesti JP, et al. (1974) Course and prognosis of sarcoidosis around the world. Am J Med 57: 847-852.
14. James DG, Sherlock S, (1994) Sarcoidosis of the liver. Sarcoidosis 11: 2-6.
15. Cozier YC, Berman JS, Palmer JR, Boggs DA, Serlin DM, et al. (2011) Sarcoidosis in black women in the United States: data from the Black Women's Health Study. Chest 139: 144-150.
16. Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC, (1997) Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 145: 234-241.
17. Sartwell PE, Edwards LB, (1974) Epidemiology of sarcoidosis in the U.S. Navy. Am J Epidemiol 99: 250-257.
18. Cummings MM, Dunner E, Schmidt RH Jr, Barnwell JB, (1956) Concepts of epidemiology of sarcoidosis; preliminary report of 1,194 cases reviewed with special reference to geographic ecology. Postgrad Med 19: 437-446.
19. Gundelfinger BF, Britten SA, (1961) Sarcoidosis in the United States Navy. Am Rev Respir Dis 84(5)Pt 2: 109-115.
20. Edmondstone WM, Wilson AG, (1985) Sarcoidosis in Caucasians, Blacks and Asians in London. Br J Dis Chest 79: 27-36.
21. Brewerton DA, Cockburn C, James DC, James DG, Neville E, (1977) HLA antigens in sarcoidosis. Clin Exp Immunol 27: 227-229.
22. Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J, (1997) HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. American journal of respiratory and critical care medicine 156: 1601-1605.
23. Rossman MD, Thompson B, Frederick M, Maliarik M, Iannuzzi MC, et al. (2003) HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 73: 720-735.
24. Grunewald J, Eklund A, Olerup O, (2004) Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am J Respir Crit Care Med 169: 696-702.
25. Rybicki BA, Walewski JL, Maliarik MJ, Kian H, Iannuzzi MC, (2005) The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites. Am J Hum Genet 77: 491-499.
26. Li Y, Wollnik B, Pabst S, Lennarz M, Rohmann E, et al. (2006) BTNL2 gene variant and sarcoidosis. Thorax 61: 273-274.
27. Hofmann S, Fischer A, Till A, Muller-Quernheim J, Hasler R, et al. (2011) A genome-wide association study reveals evidence of association with sarcoidosis at 6p12.1. Eur Respir J.
28. Rybicki BA, Levin AM, McKeigue P, Datta I, Gray-McGuire C, et al. (2011) A genome-wide admixture scan for ancestry-linked genes predisposing to sarcoidosis in African-Americans. Genes Immun 12: 67-77.
29. Miretti MM, Walsh EC, Ke X, Delgado M, Griffiths M, et al. (2005) A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. Am J Hum Genet 76: 634-646.
30. Gray-McGuire C, Sinha R, Iyengar S, Millard C, Rybicki BA, et al. (2006) Genetic characterization and fine mapping of susceptibility loci for sarcoidosis in African Americans on chromosome 5. Hum Genet 120: 420-430.
31. Song W, Nadeau P, Yuan M, Yang X, Shen J, et al. (1999) Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations. Proc Natl Acad Sci U S A 96: 6959-6963.
32. Maillard I, Adler SH, Pear WS, (2003) Notch and the immune system. Immunity 19: 781-791.
33. Noseda M, McLean G, Niessen K, Chang L, Pollet I, et al. (2004) Notch activation results in phenotypic and functional changes consistent with endothelial-to-mesenchymal transformation. Circulation research 94: 910-917.
34. Noseda M, Chang L, McLean G, Grim JE, Clurman BE, et al. (2004) Notch activation induces endothelial cell cycle arrest and participates in contact inhibition: role of p21Cip1 repression. Molecular and cellular biology 24: 8813-8822.
35. Liu ZJ, Shirakawa T, Li Y, Soma A, Oka M, et al. (2003) Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis. Molecular and cellular biology 23: 14-25.
36. Quillard T, Devalliere J, Coupel S, Charreau B, (2010) Inflammation dysregulates Notch signaling in endothelial cells: implication of Notch2 and Notch4 to endothelial dysfunction. Biochemical pharmacology 80: 2032-2041.
37. Uyttendaele H, Marazzi G, Wu G, Yan Q, Sassoon D, et al. (1996) Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. Development 122: 2251-2259.
38. Collins BJ, Kleeberger W, Ball DW, (2004) Notch in lung development and lung cancer. Seminars in cancer biology 14: 357-364.
39. Miniati D, Jelin EB, Ng J, Wu J, Carlson TR, et al. (2010) Constitutively active endothelial Notch4 causes lung arteriovenous shunts in mice. American journal of physiology Lung cellular and molecular physiology 298: L169-177.
40. Li X, Howard TD, Moore WC, Ampleford EJ, Li H, et al. (2011) Importance of hedgehog interacting protein and other lung function genes in asthma. The Journal of allergy and clinical immunology 127: 1457-1465.
41. Xu K, Moghal N, Egan SE, (2012) Notch signaling in lung development and disease. Advances in experimental medicine and biology 727: 89-98.
42. Barcellos LF, May SL, Ramsay PP, Quach HL, Lane JA, et al. (2009) High-density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions. PLoS Genet 5: e1000696.
43. Duvefelt K, Anderson M, Fogdell-Hahn A, Hillert J, (2004) A NOTCH4 association with multiple sclerosis is secondary to HLA-DR*1501. Tissue Antigens 63: 13-20.
44. Gorlova O, Martin JE, Rueda B, Koeleman BP, Ying J, et al. (2011) Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy. PLoS genetics 7: e1002178.
45. Fellay J, Ge D, Shianna KV, Colombo S, Ledergerber B, et al. (2009) Common genetic variation and the control of HIV-1 in humans. PLoS Genet 5: e1000791.
46. Grigorian A, Hurford R, Chao Y, Patrick C, Langford TD, (2008) Alterations in the Notch4 pathway in cerebral endothelial cells by the HIV aspartyl protease inhibitor, nelfinavir. BMC Neurosci 9: 27.
47. Luo X, Klempan TA, Lappalainen J, Rosenheck RA, Charney DS, et al. (2004) NOTCH4 gene haplotype is associated with schizophrenia in African Americans. Biol Psychiatry 55: 112-117.
48. Sklar P, Schwab SG, Williams NM, Daly M, Schaffner S, et al. (2001) Association analysis of NOTCH4 loci in schizophrenia using family and population-based controls. Nat Genet 28: 126-128.
49. Dubaniewicz A, Moszkowska G, (2007) DQA1*03011 allele: protective or an adverse effect on the development of sarcoidosis; preliminary study. Respiratory medicine 101: 2213-2216.
50. Todd JA, Acha-Orbea H, Bell JI, Chao N, Fronek Z, et al. (1988) A molecular basis for MHC class II-associated autoimmunity. Science 240: 1003-1009.
51. Grusby MJ, Glimcher LH, (1995) Immune responses in MHC class II-deficient mice. Annual review of immunology 13: 417-435.
52. Taipale J, Beachy PA, (2001) The Hedgehog and Wnt signalling pathways in cancer. Nature 411: 349-354.
53. Jacob J, Briscoe J, (2003) Gli proteins and the control of spinal-cord patterning. EMBO Rep 4: 761-765.
54. Kim IG, Gorman JJ, Park SC, Chung SI, Steinert PM, (1993) The deduced sequence of the novel protransglutaminase E (TGase3) of human and mouse. J Biol Chem 268: 12682-12690.
55. Alaedini A, Green PH, (2008) Autoantibodies in celiac disease. Autoimmunity 41: 19-26.
56. Uemura N, Nakanishi Y, Kato H, Saito S, Nagino M, et al. (2009) Transglutaminase 3 as a prognostic biomarker in esophageal cancer revealed by proteomics. Int J Cancer 124: 2106-2115.
57. Mehul B, Bernard D, Brouard M, Delattre C, Schmidt R, (2006) Influence of calcium on the proteolytic degradation of the calmodulin-like skin protein (calmodulin-like protein 5) in psoriatic epidermis. Exp Dermatol 15: 469-477.
58. Candi E, Oddi S, Paradisi A, Terrinoni A, Ranalli M, et al. (2002) Expression of transglutaminase 5 in normal and pathologic human epidermis. J Invest Dermatol 119: 670-677.
59. Nair RP, Stuart PE, Nistor I, Hiremagalore R, Chia NV, et al. (2006) Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. American journal of human genetics 78: 827-851.
60. Rubin LA, Amos CI, Wade JA, Martin JR, Bale SJ, et al. (1994) Investigating the genetic basis for ankylosing spondylitis. Linkage studies with the major histocompatibility complex region. Arthritis and rheumatism 37: 1212-1220.
61. Wang J, Zheng L, Lobito A, Chan FK, Dale J, et al. (1999) Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 98: 47-58.
62. Shin MS, Kim HS, Kang CS, Park WS, Kim SY, et al. (2002) Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas. Blood 99: 4094-4099.
63. Soler Artigas M, Loth DW, Wain LV, Gharib SA, Obeidat M, et al. (2011) Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nature genetics 43: 1082-1090.
64. Cecener G, Tunca B, Egeli U, Karadag M, Vatan O, et al. (2008) Mutation analysis of the FHIT gene in bronchoscopic specimens from patients with suspected lung cancer. Tumori 94: 845-848.
65. Demopoulos K, Arvanitis DA, Vassilakis DA, Siafakas NM, Spandidos DA, (2002) MYCL1, FHIT, SPARC, p16(INK4) and TP53 genes associated to lung cancer in idiopathic pulmonary fibrosis. J Cell Mol Med 6: 215-222.
66. Haase D, Meister M, Muley T, Hess J, Teurich S, et al. (2007) FRMD3, a novel putative tumour suppressor in NSCLC. Oncogene 26: 4464-4468.
67. Rosenstiel P, Sina C, End C, Renner M, Lyer S, et al. (2007) Regulation of DMBT1 via NOD2 and TLR4 in intestinal epithelial cells modulates bacterial recognition and invasion. J Immunol 178: 8203-8211.
68. Fukui H, Sekikawa A, Tanaka H, Fujimori Y, Katake Y, et al. (2011) DMBT1 is a novel gene induced by IL-22 in ulcerative colitis. Inflamm Bowel Dis 17: 1177-1188.
69. Renner M, Bergmann G, Krebs I, End C, Lyer S, et al. (2007) DMBT1 confers mucosal protection in vivo and a deletion variant is associated with Crohn's disease. Gastroenterology 133: 1499-1509.
70. Keller AD, Maniatis T, (1991) Identification and characterization of a novel repressor of beta-interferon gene expression. Genes Dev 5: 868-879.
71. Raychaudhuri S, Thomson BP, Remmers EF, Eyre S, Hinks A, et al. (2009) Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat Genet 41: 1313-1318.
72. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, et al. (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 40: 955-962.
73. Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, et al. (2011) Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 43: 246-252.
74. Han JW, Zheng HF, Cui Y, Sun LD, Ye DQ, et al. (2009) Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 41: 1234-1237.
75. Gateva V, Sandling JK, Hom G, Taylor KE, Chung SA, et al. (2009) A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 41: 1228-1233.
76. Nath SK, Han S, Kim-Howard X, Kelly JA, Viswanathan P, et al. (2008) A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus. Nat Genet 40: 152-154.
77. Adrianto I, Wen F, Templeton A, Wiley G, King JB, et al. (2011) Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nat Genet 43: 253-258.
78. ACCESS-Group (1999) Design of a case control etiologic study of sarcoidosis (ACCESS). J Clin Epidemiol 52: 1173-1186.
79. Rybicki BA, Hirst K, Iyengar SK, Barnard JG, Judson MA, et al. (2005) A sarcoidosis genetic linkage consortium: the sarcoidosis genetic analysis (SAGA) study. Sarcoidosis Vasc Diffuse Lung Dis 22: 115-122.
80. Iannuzzi MC, Maliarik MJ, Poisson LM, Rybicki BA, (2003) Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans. Am J Respir Crit Care Med 167: 1225-1231.
81. Rasmussen A, Sevier S, Kelly JA, Glenn SB, Aberle T, et al. (2011) The lupus family registry and repository. Rheumatology (Oxford) 50: 47-59.
82. Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W, et al. (2008) Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 358: 900-909.
83. Genovese G, Tonna SJ, Knob AU, Appel GB, Katz A, et al. (2010) A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9. Kidney Int 78: 698-704.
84. Xu Z, Bensen JT, Smith GJ, Mohler JL, Taylor JA, (2011) GWAS SNP Replication among African American and European American men in the North Carolina-Louisiana prostate cancer project (PCaP). Prostate 71: 881-891.
85. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, et al. (2006) Principal components analysis corrects for stratification in genome-wide association studies. NatGenet 38: 904-909.
86. Hoggart CJ, Parra EJ, Shriver MD, Bonilla C, Kittles RA, et al. (2003) Control of confounding of genetic associations in stratified populations. Am J Hum Genet 72: 1492-1504.
87. Hoggart CJ, Shriver MD, Kittles RA, Clayton DG, McKeigue PM, (2004) Design and analysis of admixture mapping studies. Am J Hum Genet 74: 965-978.
88. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
89. Howie BN, Donnelly P, Marchini J, (2009) A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 5: e1000529.
90. Durbin RM, Abecasis GR, Altshuler DL, Auton A, Brooks LD, et al. (2010) A map of human genome variation from population-scale sequencing. Nature 467: 1061-1073.
91. Kang HM, Sul JH, (2010) Service SK, Zaitlen NA, Kong SY, et al (2010) Variance component model to account for sample structure in genome-wide association studies. Nat Genet 42: 348-354.
92. Kang HM, Zaitlen NA, Wade CM, Kirby A, Heckerman D, et al. (2008) Efficient control of population structure in model organism association mapping. Genetics 178: 1709-1723.
93. Willer CJ, Li Y, Abecasis GR, (2010) METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26: 2190-2191.
94. Cochran WG, (1954) The Combination of Estimates from Different Experiments. Biometrics 10: 101-129.
95. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
96. Risch N, Merikangas K, (1996) The future of genetic studies of complex human diseases. Science 273: 1516-1517.
97. McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, et al. (2008) Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 9: 356-369.
98. Dubois PC, Trynka G, Franke L, Hunt KA, Romanos J, et al. (2010) Multiple common variants for celiac disease influencing immune gene expression. Nat Genet 42: 295-302.
99. Purcell S, Cherny SS, Sham PC, (2003) Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19: 149-150.
100. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, et al. (2010) LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26: 2336-2337.